Keyphrases
Obesity
100%
Pharmacotherapy
100%
Obesity in children
100%
Anti-obesity
100%
Obesity in Adolescents
100%
Lifestyle Modification
75%
Tolerability
25%
Clinical Trials
25%
Obesity Development
25%
Weight Loss
25%
Chronic Disease
25%
Development Pathways
25%
Pediatric Obesity
25%
Receptor Agonist
25%
Metabolic Surgery
25%
Comprehensive Care
25%
A1 Receptor
25%
Adipose Tissue Mass
25%
Comprehensive Treatment
25%
Glucagon-like
25%
Obesogenic Environment
25%
Co-agonist
25%
Biological Predispositions
25%
Weight Set
25%
Long-term Health Outcomes
25%
Chronic Care Model
25%
Pediatric Weight Management Intervention
25%
Incretin Receptors
25%
Future Therapies
25%
Safety Efficacy
25%
Medicine and Dentistry
Drug Therapy
100%
Adolescence
100%
Anti-Obesity Medication
100%
Lifestyle Modification
75%
Clinical Trial
25%
Pediatrics
25%
Childhood Obesity
25%
Adipose Tissue
25%
Receptor
25%
Chronic Disease
25%
Health Outcomes
25%
Prevalence
25%
Weight Management
25%
Disease Predisposition
25%
Body Weight
25%
Glucagon-Like Peptide-1 Agonist
25%
Incretin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Clinical Trial
33%
Tolerability
33%
Chronic Disease
33%
Receptor
33%
Prevalence
33%
Glucagon Like Peptide 1 Receptor Agonist
33%
Disease Predisposition
33%
Childhood Obesity
33%
Incretin
33%